Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joshua T. Ellsworth. (2022) Spice, vulnerability, and victimization: Synthetic cannabinoids and interpersonal crime victimization among homeless adults. Substance Abuse 43:1, pages 32-38.
Read now
Read now
Adriana M. Joseph, Marc W. Manseau, Monique Lalane, Amit Rajparia & Crystal Fuller Lewis. (2017) Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting. The American Journal of Drug and Alcohol Abuse 43:1, pages 117-122.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Articles from other publishers (18)
Orion Santangelo, Julie Marie Baldwin & John Stogner. (2022) Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans. International Journal of Drug Policy 106, pages 103756.
Crossref
Crossref
Yasemin Sanal Özcan. (2022) Synthetic Cannabinoid Usage Characteristics and Perceptions of Addicts in the Treatment Process. The Bulletin of Legal Medicine 27:1, pages 1-9.
Crossref
Crossref
Alessio Fiorentini, Filippo Cantù, Camilla Crisanti, Guido Cereda, Lucio Oldani & Paolo Brambilla. (2021) Substance-Induced Psychoses: An Updated Literature Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Zsuzsa Kaló, Szilvia Kassai, József Rácz & Marie Claire Van Hout. (2018) Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries. International Journal of Mental Health and Addiction 18:1, pages 160-176.
Crossref
Crossref
Laura Orsolini, Stefania Chiappini, Duccio Papanti, Domenico De Berardis, John M. Corkery & Fabrizio Schifano. (2019) The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Frontiers in Psychiatry 10.
Crossref
Crossref
Işılay BALCI, Ali Yılmaz, Yeşim Yetiş, Emrah Emiral & KENAN KARBEYAZ. (2019) Analysis of Deaths Related to Synthetic Cannabinoid (“Bonsai”) in Eskişehir, Turkey. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, pages 1459-1469.
Crossref
Crossref
Huiqiong Deng, Christopher D. Verrico, Thomas R. Kosten & David A. Nielsen. (2018) Psychosis and synthetic cannabinoids. Psychiatry Research 268, pages 400-412.
Crossref
Crossref
Papanti Duccio, Schifano Fabrizio & Orsolini Laura. 2018. The Complex Connection Between Cannabis and Schizophrenia. The Complex Connection Between Cannabis and Schizophrenia
199
220
.
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Marie Claire Van Hout & Evelyn Hearne. (2016) User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. International Journal of Mental Health and Addiction 15:3, pages 565-579.
Crossref
Crossref
Andreas Carlsson, Sandra Lindberg, Xiongyu Wu, Simon Dunne, Martin Josefsson, Crister Åstot & Johan Dahlén. (2016)
Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1
H
-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1
H
-indol-3-yl(adamantan-1-yl)methanone
. Drug Testing and Analysis 8:10, pages 1015-1029.
Crossref
Crossref
Kim Wolff. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
147
164
.
Liana Fattore. (2016) Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry 79:7, pages 539-548.
Crossref
Crossref
Benzi Kluger, Piera Triolo, Wallace Jones & Joseph Jankovic. (2015) The therapeutic potential of cannabinoids for movement disorders. Movement Disorders 30:3, pages 313-327.
Crossref
Crossref
Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, Rebecca L. Hartman, Sandrine Pirard & Marilyn A. Huestis. (2014) Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence 144, pages 12-41.
Crossref
Crossref
Karla D. Wagner, Richard F. Armenta, Alexis M. Roth, Jane C. Maxwell, Jazmine Cuevas-Mota & Richard S. Garfein. (2014) Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug and Alcohol Dependence 141, pages 99-106.
Crossref
Crossref
Max Spaderna, Peter H. Addy & Deepak Cyril D’Souza. (2013) Spicing things up: synthetic cannabinoids. Psychopharmacology 228:4, pages 525-540.
Crossref
Crossref